Grandview Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-223
Closed -$56K 123
2021
Q1
$56K Buy
+223
New +$53.2K 0.03% 192
2020
Q1
Sell
-948
Closed -$228K 14
2019
Q4
$228K Sell
948
-361
-28% -$79.6K 0.22% 83
2019
Q3
$253K Buy
1,309
+114
+10% +$21.9K 0.23% 91
2019
Q2
$220K Buy
1,195
+125
+12% +$22.4K 0.2% 97
2019
Q1
$203K Sell
1,070
-3
-0.3% -$573 0.19% 92
2018
Q4
$209K Buy
+1,073
New +$209K 0.22% 85

Other funds holding AMGN

Grandview Asset Management's AMGN Position: Q2 2021 in Review

Grandview Asset Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 223 shares — an estimated $56K sold.

Grandview Asset Management first reported a position in AMGN in Q4 2018 and held it in 6 quarters. The position peaked at $253K in Q3 2019. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Grandview Asset Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Grandview Asset Management sold 223 Amgen shares in Q2 2021, an estimated $56K.
  • Grandview Asset Management first reported a position in Amgen in Q4 2018 and held it in 6 quarters.
  • Grandview Asset Management's Amgen position peaked at $253K in Q3 2019.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Grandview Asset Management's 13F filing for Q2 2021, filed 21 Jul 2021.